""The new Wegovy subscription program removes barriers, providing people who enroll with a simple, affordable, and consistent way to start and stay on genuine, FDA-approved treatment.""
""By providing predictable monthly pricing, multi-month options, and access through trusted telehealth providers, this program aims to support a more manageable way for people to stay on treatment and focus on achieving meaningful, sustainable weight-loss outcomes.""
Novo Nordisk introduced a subscription program for Wegovy, aimed at reducing cost uncertainty for patients. The program offers savings of up to $600 annually for the pill and $1,200 for injections with a 12-month subscription. Patients can select from three plans: $329 per month for three months, $299 for six months, and $249 for twelve months. The initiative is designed to provide affordable access to FDA-approved treatments and is available through various telehealth providers, with plans for further expansion.
Read at Fast Company
Unable to calculate read time
Collection
[
|
...
]